XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 175 filers reported holding XENON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $99,836,741 | +77.3% | 2,560,573 | +95.8% | 3.13% | +72.6% |
| Q1 2024 | $56,309,874 | -25.8% | 1,308,011 | -20.6% | 1.82% | -34.9% |
| Q4 2023 | $75,875,145 | +5.6% | 1,647,311 | -21.7% | 2.79% | +22.7% |
| Q3 2023 | $71,852,007 | +2.1% | 2,103,396 | +15.0% | 2.27% | -1.3% |
| Q2 2023 | $70,391,591 | -8.0% | 1,828,353 | -14.4% | 2.30% | -8.8% |
| Q1 2023 | $76,487,167 | +25.3% | 2,137,110 | +38.0% | 2.52% | +23.3% |
| Q4 2022 | $61,041,977 | – | 1,548,110 | – | 2.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,754,266 | $107,388,831 | 7.33% |
| Altium Capital Management LP | 360,600 | $14,059,794 | 5.74% |
| Affinity Asset Advisors, LLC | 994,227 | $38,764,911 | 4.47% |
| First Light Asset Management, LLC | 1,306,260 | $50,931,077 | 4.46% |
| Nan Fung Group Holdings Ltd | 106,680 | $4,159,453 | 4.44% |
| Ally Bridge Group (NY) LLC | 169,369 | $6,603,697 | 3.93% |
| TLS Advisors LLC | 32,956 | $1,285 | 3.22% |
| BRAIDWELL LP | 2,560,573 | $99,836,741 | 3.13% |
| Paradigm Biocapital Advisors LP | 2,043,280 | $79,667,487 | 3.05% |
| BRIDGER MANAGEMENT, LLC | 146,800 | $5,723,732 | 2.94% |